<- Go Home
Axonics, Inc.
Axonics, Inc. develops therapies for urinary and bowel dysfunction. The company provides therapies and solutions for these conditions, offering the Axonics System for healthcare professionals and patients. It delivers coding and billing resources and support, along with information and resources through its website. Clients can sign up for updates and receive information about products and services. The company was founded in 2012 and is based in Irvine, California.
Market Cap
$3.6B
Volume
688.3K
Cash and Equivalents
$239.5M
EBITDA
$5.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$330.8M
Profit Margin
76.59%
52 Week High
$71.05
52 Week Low
$55.09
Dividend
N/A
Price / Book Value
5.46
Price / Earnings
-634.68
Price / Tangible Book Value
7.53
Enterprise Value
$3.3B
Enterprise Value / EBITDA
352.92
Operating Income
-$7.2M
Return on Equity
0.89%
Return on Assets
-0.63
Cash and Short Term Investments
$345.2M
Debt
$32.5M
Equity
$664.5M
Revenue
$431.9M
Unlevered FCF
$16.8M
Sector
Health Care Equipment and Supplies
Category
N/A